Bram Brouwers
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Adipose Tissue and Metabolism, Diet, Metabolism, and Disease, Diet and metabolism studies, Muscle metabolism and nutrition
Most-Cited Works
- → Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis(2024)663 cited
- → Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial(2022)442 cited
- → Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial(2024)205 cited
- → Exercise training elicits superior metabolic effects when performed in the afternoon compared to morning in metabolically compromised humans(2020)112 cited
- → Distinct lipid droplet characteristics and distribution unmask the apparent contradiction of the athlete's paradox(2018)109 cited
- → Effects of exercise training on intrahepatic lipid content in humans(2016)93 cited
- → Exercise training reduces intrahepatic lipid content in people with and people without nonalcoholic fatty liver(2017)68 cited
- → Long–echo time MR spectroscopy for skeletal muscle acetylcarnitine detection(2014)67 cited
- → Exercise training-induced effects on the abdominal subcutaneous adipose tissue phenotype in humans with obesity(2018)64 cited
- → Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes(2017)57 cited